Welcome to our dedicated page for Clarivate Plc news (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate Plc stock.
Clarivate Plc (NYSE: CLVT) is described as a leading global provider of transformative intelligence, with news that reflects its activities across Academia & Government, Intellectual Property and Life Sciences & Healthcare. Company announcements frequently highlight new AI-powered tools, analytical reports and customer adoptions that illustrate how Clarivate combines enriched data, analytics and workflow software.
Recent news includes the launch of the Web of Science Research Assistant, a generative AI-powered tool that helps researchers conduct natural-language searches, perform literature reviews and explore visualizations based on more than 120 years of publication and citation data. Clarivate also reports on studies such as the Pulse of the Library report, which surveys thousands of librarians worldwide about AI adoption, open science and budget pressures, and on the annual Highly Cited Researchers list, which recognizes researchers whose work has had broad influence based on Web of Science data.
In Intellectual Property, Clarivate issues updates on solutions like IPfolio and Derwent Patent Monitor, including customer selections by organizations such as Nissan Motor Co., Ltd. and FUJIFILM Holdings Corporation. These stories emphasize how IP management platforms and AI-enabled patent review tools support more efficient IP operations and collaboration between IP and R&D teams.
Life sciences and healthcare news often centers on Clarivate analyses such as the Drugs to Watch report and Companies to Watch reports, which identify emerging therapies and innovative companies using integrated, AI-enhanced datasets. Visitors to this news page can follow Clarivate’s product launches, research reports, customer case studies and investor-related announcements to understand how the company is applying data and AI across its core markets.
Dana Incorporated (NYSE: DAN) has appointed Timothy R. Kraus as its new senior vice president and chief financial officer, succeeding Jonathan Collins, who will join Clarivate plc (NYSE: CLVT). Kraus, a Dana veteran with over a decade at the company, previously served as senior vice president of finance and treasurer, overseeing global treasury operations and strategic acquisitions. CEO James Kamsickas acknowledged Kraus's crucial role in Dana's transformation strategy, enhancing innovation and balance sheet strength. Collins will assist in the transition until December 15, 2021.
Clarivate (NYSE: CLVT) announced a leadership change with the departure of CFO Richard Hanks, effective December 16, 2021. His successor, Jonathan Collins, currently CFO of Dana (NYSE: DAN), will take over to drive the company's ongoing growth. Hanks will assist during the transition until April 1. Collins brings extensive experience from Dana and ProQuest, where he held senior financial roles. Clarivate's Executive Chairman praised Hanks for his contributions over the past five years and expressed confidence in Collins' ability to lead the financial strategy moving forward.
Clarivate has successfully completed its acquisition of ProQuest for $5.3 billion, enhancing its position as a global leader in information and analytics. This acquisition, announced on May 17, 2021, adds ProQuest's software, content, and analytics capabilities to Clarivate's portfolio. The combined entity now boasts over 11,000 employees serving 45,000 customers worldwide. The integration aims to unlock synergies and offer enriched services to research-focused organizations, while maintaining investment in existing product lines. Key leadership changes include Jonathan Collins as the new CFO.
Clarivate Plc (NYSE: CLVT) announced that its Executive Chairman Jerre Stead and CFO Richard Hanks will present at two upcoming virtual investor conferences. The presentations will take place at the BofA Securities Leveraged Finance Conference on November 30, 2021, at 8:15 am ET, and the Barclays Global Technology, Media, and Telecommunications Conference on December 7, 2021, at 3:35 pm ET. Webcasts for both events will be available for live access and replay. For more details, please visit Clarivate's website.
Clarivate Plc (NYSE:CLVT) has released its 2021 Highly Cited Researchers list, identifying 6,602 researchers globally, with 39.7% based in the United States, a decrease from previous years. Mainland China has seen significant growth, now boasting 935 researchers, nearly doubling its presence in four years. Key institutions include Harvard University with 214 researchers. This reflects a trend of globalization in research, with declines observed in the U.S. and U.K.
Clarivate Plc (NYSE: CLVT) announced that Executive Chairman Jerre Stead and CFO Richard Hanks will present at virtual investor conferences in November 2021. The first event is the RBC Capital Markets Global Technology Conference on November 17, 2021, at 9:35 AM ET, with a live webcast available for replay. The second event is the BofA Securities 2021 Leveraged Finance Conference on November 30, 2021, at 8:15 AM ET, also with a live webcast accessible for replay. For more details, visit clarivate.com.
Clarivate Plc (NYSE:CLVT) has been recognized by Forrester in their latest B2B2C Journey Mapping reports. These reports highlight the importance of transparency and trust in enhancing customer experiences. Clarivate's Customer Experience (CX) Services emphasizes the need for effective customer journey mapping, beginning with understanding customer feedback. The company also stresses the significance of recognizing partners' roles in customer experiences. This recognition underscores Clarivate's commitment to improving customer insights and driving business success.
Clarivate has partnered with the Biomedical Advanced Research and Development Authority (BARDA) to expedite the development of drug therapeutics that can serve as medical countermeasures (MCMs) for chlorine and sulfur mustard injuries. This collaboration will utilize machine learning and artificial intelligence to identify and repurpose existing FDA-approved drugs. Funding from BARDA will facilitate target identification and analyses, aiming to provide quicker responses to chemical exposure incidents. This initiative is part of BARDA's ReDIRECT program to enhance public health preparedness.
Summary not available.
On November 2, 2021, Clarivate Plc (NYSE: CLVT) announced a Virtual Investor Day scheduled for November 9, 2021. The event will provide updates on the company's business, with presentations from 10:00 AM to 1:00 PM Eastern Time. Participants can join via webcast through the Clarivate Investor Relations website. A replay will also be available afterwards. Clarivate aims to accelerate innovation through trusted information and insights, helping clients navigate complex challenges in science and intellectual property.